Navigation Links
Anthera Pharmaceuticals Forms Scientific Advisory Board
Date:2/5/2008

- Renowned Clinical Authorities to Advise on Development of New Drug

Candidate to Treat Autoimmune Disease -

SAN MATEO, Calif., Feb. 5 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately-held drug development company, announced today that it has appointed the first five members of its Scientific Advisory Board for A-623, a peptide fusion protein licensed from Amgen in December 2007 for the treatment of systemic lupus erythematosus (SLE) and other autoimmune diseases. The scientific advisory board will include Jill Buyon, M.D., Betty Diamond, M.D., Kenneth Kalunian, M.D., David Wofsy, M.D., and Debra Zack, M.D., Ph.D.

"We are pleased to have recruited such an outstanding team of internationally recognized experts in the field of autoimmune disease," said Paul F. Truex, President and Chief Executive Officer of Anthera Pharmaceuticals, Inc. "All have made significant contributions to the scientific understanding of lupus. The extraordinary magnitude of research and clinical expertise assembled on this board will be invaluable as we advance our clinical development programs for A-623."

-- Jill Buyon, M.D. is Professor of Medicine, New York University School

of Medicine and Vice Chairman of the Department of Rheumatology at NYU

Hospital for Joint Diseases.

-- Betty Diamond, M.D. is Head of The Center for Autoimmune and

Musculoskeletal Disease at the Feinstein Institute for Medical

Research and is on the faculty at Albert Einstein College of Medicine.

-- Kenneth Kalunian, M.D. is Professor of Medicine in the Division of

Rheumatology at the University of California, San Diego School of

Medicine.

-- David Wofsy, M.D. is Professor of Medicine and Microbiology/Immunology

at the University of California, San Francisco.

-- Debra Zack, M.D., Ph.D. is the Executive Director in Inflammation

Global Development
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
3. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
5. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
6. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
7. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
8. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Access Pharmaceuticals Announces $2.7 Million New Equity
10. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
11. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... HONG KONG , July 31, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... with the U.S. Securities and Exchange Commission. The filed ... year ended March 31, 2015. The Form 20-F can ...
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, a ... Sales & Marketing Director. , With more than 25 years of experience ... reinforcing Tronics’ business development activities worldwide. He brings to the company his strong ...
(Date:7/30/2015)... 2015   Senomyx , Inc. (NASDAQ: SNMX ... to discover, develop, and commercialize novel flavor ingredients for ... financial results for the second quarter 2015. ... remain on track to achieve our commercial and financial ... of the Company. "Since our last quarterly earnings report, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
Breaking Biology Technology:China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
... DIEGO, May 12 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Care Conference on Tuesday, May 19, 2009 at ... Daniel M. Bradbury, president and chief executive officer of Amylin ... session will be webcast, and a recording will be made ...
... 12 Joseph F. Finn, Jr., C.P.A. ("Finn"), ... have been assigned to him for the benefit of ... molecule designed to inhibit the activity of galectin-3, a ... of human cancers and whose over-expression is associated with ...
... wide array of ACCU-CHEK programs centered around Behavior ... better self-care.INDIANAPOLIS, May 12 Roche, the maker ... pumps, announced today its long-term commitment to tackle ... Change through Patient Engagement (SM) program - a ...
Cached Biology Technology:Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors 2Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes 2Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes 3
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... February 2, 2014, Shenzhen, China - Researchers from Yellow ... BGI-Shenzhen and other institutes have successfully decoded the first ... Cynoglossus semilaevis ), providing insights into ZW sex chromosome ... generated in this project also lay foundation on the ...
... cycles and there are also weight loss cycles. Almost ... weekends. What separates the slim from the heavy isn,t ... much they lose during the weekdays. In this study, ... researchers from the VTT Technical Research Centre of Finland ...
... on a daily basis that could lead to cancers ... system, Melbourne scientists have found. The research team ... the immune system was responsible for eliminating potentially cancerous ... developed into B-cell lymphomas (also known as non-Hodgkin,s lymphomas). ...
Cached Biology News:Two papers unraveled the mystery of sex determination and benthic adaptation of the flatfish 2Two papers unraveled the mystery of sex determination and benthic adaptation of the flatfish 3Two papers unraveled the mystery of sex determination and benthic adaptation of the flatfish 4Whether your lose or gain weight depends on weekdays 2Red alert: Body kills 'spontaneous' blood cancers on a daily basis 2
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
... processes up to 48 lanes, 24 bi-directional, ... can be from either slab gel or ... chemistries. The detection parameters in Explorer have ... consistency. We have built Explorer for ...
... ISO 9001:2000 Certified USDA Research Registered ... SOP's Training AALAS Certified Technicians ... Procedures GLP Documentation Upon Request Focus ... point for all your custom immunology service ...
...
Biology Products: